CAVEAT: venetoclax and high dose chemo for elderly AML

Andrew Wei, MBBS, PhD, of Monash University, Melbourne, Australia, presented results from the CAVEAT trial (ACTRN12616000445471) at the 23rd Congress of the European Hematological Association (EHA) 20... Author: VJHemOnc Added: 07/31/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts